CClinicalTrials.gg
CompletedNCT01768000Updated Mar 1, 2016Results posted

The Family Cognitive Adaptation Training Manual: A Test of Effectiveness

An interventional study of Family Cognitive Adaptation Training in Psychosis, sponsored by Centre for Addiction and Mental Health. Completed at 1 site in Canada. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2016-03-01.

Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The purpose of this study is to examine the effectiveness of family cognitive adaptation training, including its impact on functioning and caregiver burden. Families that receive the manual will be compared with a control group of families that will not receive the manual. The larger goal is to add to the tools family members have access to better support their family members with schizophrenia.

Read the detailed description

Efforts to address the cognitive impacts of schizophrenia can be broadly defined as falling into either compensatory or restorative categories. Restorative interventions, such as cognitive remediation, have shown promise in reducing cognitive deficits and improving functional outcomes (McGurk et al., 2007). In contrast, compensatory approaches such as Cognitive Adaptation Training work around cognitive deficits by changing the client's natural environment to support improved functioning. These compensatory strategies serve to bypass cognitive deficits and negative symptoms by organizing belongings and creating reminders and environmental cues to support specific adaptive behaviors. An example includes the individual packaging of clothes to be worn by day, to simplify the process of choosing what to wear and decrease the likelihood of clients impulsively putting on too many clothes or otherwise dressing in a manner that is not a good fit for the climate or social settings (Draper et al., 2009; Maples \& Velligan, 2008).

Cognitive Adaptation Training (CAT) is a manualized intervention that was developed to help individuals compensate for the cognitive deficits associated with schizophrenia. CAT interventions commence with a neuropsychological assessment of clients to determine the best profile of strategies to be implemented for the specific cognitive classification within which the person is placed. Interventions are based on two dimensions 1) level of executive functioning (as determined by scores on a set of neurocognitive tests) and 2) whether the behaviour of the individual is characterized more by apathy (poverty of speech and movement and difficulty initiating behaviours), disinhibition (distractibility and impulsivity) or a combination of the two. Clinicians then develop and implement an individualized set of strategies that address key domains such as hygiene, safety, dress, and medication. These strategies are then altered for strengths or weaknesses in the areas of attention, memory, and fine motor skills. For example, for someone with poor attention, the colour of signs can be changed regularly or florescent colours can be used to capture attention. For someone with memory problems (particularly those with good auditory attention) audiotapes can be used to sequence behaviour.

CAT interventions are established and maintained in the home during monthly to weekly visits from a CAT therapist/trainer with the intervention typically lasting 9 months in most of the trials that have taken place to date

Outcomes of randomized trials of CAT have been promising. Compared to control conditions, clients receiving CAT have lower levels of symptomatology, lower relapse rates, higher levels of adaptive functioning, better quality of life, and better medication adherence (Velligan et al., 2000; 2002; 2007; 2008a; 2008b). In general, CAT has been shown to be beneficial for individuals with schizophrenia who vary both in degree and type of functional impairment.

The support and involvement of family in the care of individuals with schizophrenia is both one of the most important contributors to wellness and recovery and is also, unfortunately, one of the least acknowledged components of the recovery process. A high proportion of persons with severe mental illness stay in touch with family and the involvement of family in care has been associated with better clinical outcomes, improved quality of life, and less use of hospitalization (e.g., Fischer et al., 2008). Despite evidence of the importance of family in the recovery process, the contribution of family is often not adequately appreciated by treatment providers, and contact with providers is often limited. Similarly under-developed are evidence-based tools to assist families in their efforts to support the recovery of their loved ones.

It is within this context that the development of a family member version of CAT is a very promising avenue to explore. While some elements of CAT require or are otherwise optimized by administration by a mental health professional (e.g., neuropsychological testing; targeting interventions based upon ongoing clinical evaluation), there are many standard components of CAT that can be readily implemented by a family member or other key support. Examples include CAT interventions such as visual reminders regarding medication, arranging cleaning supplies in the kitchen to reinforce cleaning routines, and assisting in the use of a calendar for scheduling. We have developed a tool that facilitates family members implementing CAT components that do not require professional administration.

The initial 'beta' version of Family CAT was developed in close collaboration between Dr. Velligan's team at the University of Texas, the group implementing CAT at the CAMH site led by Dr. Kidd, and CAMH Social Workers. This 'beta' version is currently in the process of having its content reviewed by 6 families to obtain feedback regarding how readily it can be understood. Based on this feedback, we will make edits and produce the final version to be used in the trial proposed in this protocol.

02

Conditions studied

  • Psychosis

Keywords

  • Psychosis
  • Psychosis NOS
  • Schizophrenia
  • Schizoaffective Disorder
  • Bipolar Disorder
03

In context

Psychotic Disorders

1,626 studies on the registry are indexed under Psychotic Disorders; 293 are open to participants now.

This study's enrollment of 40 is below the median of 70 across 1,333 interventional studies indexed under Psychotic Disorders.

Browse Psychotic Disorders studies →

Lead sponsor

Centre for Addiction and Mental Health is the lead sponsor of 327 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • the key family member/support is actively involved in the support of the individual with schizophrenia and regularly visits them (i.e., once a week or more frequently) in their home environment
  • the individual being supported is identified (self-identified and identified by the family member) as having a primary diagnosis of schizophrenia
  • the individual with schizophrenia is not in crisis or experiencing other forms of instability (e.g., imminent loss of housing) per verbal report that would threaten the implementation of the manual strategies
  • proficiency in English

Exclusion criteria

Exclusion criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Family Cognitive Adaptation Training

    Participants in this group will receive the Family CAT manual and DVD

    Behavioral: Family Cognitive Adaptation Training

  • No intervention
    Control group

    Participants in this arm will support their family members as usual, and will not receive the Family CAT manual and DVD provided to those in the experimental arm of the study.

Interventions

  • BehavioralFamily Cognitive Adaptation Training

    Family CAT is a 4 month manualised intervention designed to be administered by families independent of clinician support. A self scoring checklist is provided to assess and tailor Family CAT to the individual, along with descriptions of strategies for bathing, dressing, dental hygiene, make-up, toileting, housekeeping/care of living quarters, laundry, grocery shopping, transportation, management of money and consumables, medication management, social skills, communication and telephone use, leisure skills, work skills, and orientation. Family members will watch the DVD to gain insight into how the strategies can be implemented in real world settings. Having identified the areas of need, family members will administer the interventions and evaluate their effectiveness for the individual.

    Also known as: Family CAT

06

What researchers measure

Primary outcomes

  1. Multnomah Community Ability Scale (MCAS)

    The Multnomah Community Ability Scale (MCAS; Barker et al., 1994) is a 17-item scale assessing functionality in four domains - health, adaptation, social skills and behaviour. Ratings are made on the basis of an interview with the patient and their family member. The MCAS generates a total score ranging from 17 to 85. Items on the MCAS are scored on a five-point scale. The four total domain scores ranges are - health, 5-25; adaptation, 3-15; social skills, 5-25; behaviour, 4-20. Lower ratings indicate less ability. Higher ratings usually mean an assessment of greater ability.

    Time frame: 4 months following baseline assessment

Secondary outcomes

  1. Brief Adherence Rating Scale (BARS)

    The Brief Adherence Rating Scale (BARS; Byerly et al., 2008) is a 4-item, valid, reliable, sensitive, measure with which to obtain specific estimates of antipsychotic medication adherence of outpatients with schizophrenia. A total percentage score on a scale ranging from 0 to 100, with 0 indicating less adherence and 100 total adherence.

    Time frame: 4 months following baseline assessment

  2. Satisfaction With Life Scale

    8 out of 18 items from the Satisfaction With Life Scale (Test et al., 2005) will measure the perceived quality of life of the individual with schizophrenia by tapping into global satisfaction in domains relevant to CAT (e.g., How satisfied are you with yourself on the whole? - 5 point scale, not at all - great deal). This scale is well-validated with a schizophrenia population and is being shortened as not all items are relevant to CAT nor expected to be sensitive to change in a 4 month period, and there is a need to abbreviate the battery to reduce the risk of fatigue in a lengthy phone interview. These 8 items comprise four domains of social relationships, employment/work, social and present life and living situation. A low score indicates less satisfaction in these domains and a higher score indicating greater satisfaction. Total scores can range from 8-40 and subscale scores range from 1-5.

    Time frame: 4 months following baseline assessment

  3. Involvement Evaluation Questionnaire (IES)

    The 31-item Involvement Evaluation Questionnaire (IEQ; Van Wijngaarden et al., 2000) measures caregiver burden. It has been validated for caregivers of individuals with schizophrenia, covers a broad domain of caregiving consequences and refers to burden experienced within the past 4 weeks. Mean scores are calculated for the total scale and sub-scales. Total scores can range from 29 to 145 with sub-scale domains ranging - tension, 9-45; supervision, 6-30; worrying, 6-30; and urging, 8-40. Lower total and subscale scores indicate less burden and higher scores greater level of caregiver burden.

    Time frame: 4 months following baseline assessment

07

Results

Posted Mar 1, 2016

Participant flow

Recruited between March 2013 and February 2014 in Ontario, Canada.

Participant flow — Overall Study
MilestoneFamily Cognitive Adaptation Training - CaregiversControl Group - CaregiversFamily Cognitive Adaptation Training - Family MembersControl Group - Family Members
Started10101010
Completed9898
Not completed1212

Outcome measures

PrimaryMultnomah Community Ability Scale (MCAS)

The Multnomah Community Ability Scale (MCAS; Barker et al., 1994) is a 17-item scale assessing functionality in four domains - health, adaptation, social skills and behaviour. Ratings are made on the basis of an interview with the patient and their family member. The MCAS generates a total score ranging from 17 to 85. Items on the MCAS are scored on a five-point scale. The four total domain scores ranges are - health, 5-25; adaptation, 3-15; social skills, 5-25; behaviour, 4-20. Lower ratings indicate less ability. Higher ratings usually mean an assessment of greater ability.

Time frame:
4 months following baseline assessment
Reported as:
Mean · units on a scale
Multnomah Community Ability Scale (MCAS)
units on a scaleFamily Cognitive Adaptation Training - CaregiversControl Group - CaregiversFamily Cognitive Adaptation Training - Family MembersControl Group - Family Members
Total67.78 ± 5.7074.63 ± 5.4570.00 ± 5.1074.38 ± 5.15
Health21.67 ± 2.3422.13 ± 2.3621.56 ± 1.8821.50 ± 1.93
Adaptation10.89 ± 2.5713.25 ± 1.6711.78 ± 1.9213.00 ± 1.69
Social Skills17.44 ± 3.1720.63 ± 2.5018.33 ± 3.8720.75 ± 2.71
Behaviour17.78 ± 1.7218.63 ± 1.7718.33 ± 1.8019.13 ± 1.36
SecondaryBrief Adherence Rating Scale (BARS)

The Brief Adherence Rating Scale (BARS; Byerly et al., 2008) is a 4-item, valid, reliable, sensitive, measure with which to obtain specific estimates of antipsychotic medication adherence of outpatients with schizophrenia. A total percentage score on a scale ranging from 0 to 100, with 0 indicating less adherence and 100 total adherence.

Time frame:
4 months following baseline assessment
Reported as:
Mean · units on a scale
Brief Adherence Rating Scale (BARS)
units on a scaleFamily Cognitive Adaptation Training - CaregiversControl Group - CaregiversFamily Cognitive Adaptation Training - Family MembersControl Group - Family Members
Brief Adherence Rating Scale (BARS)77.22 ± 35.9887.50 ± 35.3659.33 ± 44.0388.75 ± 31.82
SecondarySatisfaction With Life Scale

8 out of 18 items from the Satisfaction With Life Scale (Test et al., 2005) will measure the perceived quality of life of the individual with schizophrenia by tapping into global satisfaction in domains relevant to CAT (e.g., How satisfied are you with yourself on the whole? - 5 point scale, not at all - great deal). This scale is well-validated with a schizophrenia population and is being shortened as not all items are relevant to CAT nor expected to be sensitive to change in a 4 month period, and there is a need to abbreviate the battery to reduce the risk of fatigue in a lengthy phone interview. These 8 items comprise four domains of social relationships, employment/work, social and present life and living situation. A low score indicates less satisfaction in these domains and a higher score indicating greater satisfaction. Total scores can range from 8-40 and subscale scores range from 1-5.

Time frame:
4 months following baseline assessment
Reported as:
Mean · units on a scale
Satisfaction With Life Scale
units on a scaleFamily Cognitive Adaptation Training - Family MembersControl Group - Family Members
Social Relationships2.06 ± 0.922.18 ± 0.73
Employment/Work1.63 ± 1.162.17 ± 0.41
Social & Present Life2.00 ± 0.992.29 ± 0.76
Living Situation3.11 ± 0.493.00 ± 0.66
SecondaryInvolvement Evaluation Questionnaire (IES)

The 31-item Involvement Evaluation Questionnaire (IEQ; Van Wijngaarden et al., 2000) measures caregiver burden. It has been validated for caregivers of individuals with schizophrenia, covers a broad domain of caregiving consequences and refers to burden experienced within the past 4 weeks. Mean scores are calculated for the total scale and sub-scales. Total scores can range from 29 to 145 with sub-scale domains ranging - tension, 9-45; supervision, 6-30; worrying, 6-30; and urging, 8-40. Lower total and subscale scores indicate less burden and higher scores greater level of caregiver burden.

Time frame:
4 months following baseline assessment
Reported as:
Mean · units on a scale
Involvement Evaluation Questionnaire (IES)
units on a scaleFamily Cognitive Adaptation Training - CaregiversControl Group - Caregivers
Total57.72 ± 9.6649.25 ± 11.15
Tension15.50 ± 4.2714.13 ± 2.85
Supervision8.22 ± 2.057.50 ± 1.07
Worrying17.89 ± 4.3115.25 ± 4.40
Urging20.56 ± 7.1316.38 ± 5.66

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Family Cognitive Adaptation Training - Caregivers—0/10 (0%)0/10 (0%)
Control Group - Caregivers—0/10 (0%)0/10 (0%)
Family Cognitive Adaptation Training - Family Members—0/10 (0%)0/10 (0%)
Control Group - Family Members—0/10 (0%)0/10 (0%)

Baseline characteristics

Baseline Analysis includes all participants recruited into the study that completed the entire baseline assessment.

Age, Categorical
Age, Categorical(Participants)Family Cognitive Adaptation Training - Family MembersFamily Cognitive Adaptation Training - CaregiversControl Group - Family MembersControl Group - CaregiversTotal
<=18 years00000
Between 18 and 65 years1099836
>=65 years01012
Sex: Female, Male
Sex: Female, Male(Participants)Family Cognitive Adaptation Training - Family MembersFamily Cognitive Adaptation Training - CaregiversControl Group - Family MembersControl Group - CaregiversTotal
Female274619
Male835319
Race/Ethnicity, Customized
Race/Ethnicity, Customized(participants)Family Cognitive Adaptation Training - Family MembersFamily Cognitive Adaptation Training - CaregiversControl Group - Family MembersControl Group - CaregiversTotal
Asian East11002
Asian South13105
Asian South East10001
Black Canadian10113
Latin American01001
White Canadian555318
White European00134
Other00011
Asian (not specified)00112
Not specified10001
Region of Enrollment
Region of Enrollment(participants)Family Cognitive Adaptation Training - Family MembersFamily Cognitive Adaptation Training - CaregiversControl Group - Family MembersControl Group - CaregiversTotal
Canada10109938
Employment status
Employment status(participants)Family Cognitive Adaptation Training - Family MembersFamily Cognitive Adaptation Training - CaregiversControl Group - Family MembersControl Group - CaregiversTotal
Full-time141410
Part-time12137
In school30104
Unemployed515112
Retired00101
Contract work03003
Not specified00011
Level of education
Level of education(participants)Family Cognitive Adaptation Training - Family MembersFamily Cognitive Adaptation Training - CaregiversControl Group - Family MembersControl Group - CaregiversTotal
Completion of graduate school02024
Completion of undergraduate university/college052411
Partial undergraduate university/college725014
Completion of high school11125
Partial high school10102
Not specified10012
Housing
Housing(Participants)Family Cognitive Adaptation Training - Family MembersFamily Cognitive Adaptation Training - CaregiversControl Group - Family MembersControl Group - CaregiversTotal
Own/rent apartment or home0NA2NANA
Supported housing1NA1NANA
Live with family9NA6NANA
08

Study locations

1 site
  • Centre for Addiction and Mental Health
    Toronto, Ontario, Canada
09

References and documents

Publications

  • Alphs LD, Summerfelt A, Lann H, Muller RJ. The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia. Psychopharmacol Bull. 1989;25(2):159-63. No abstract available. PubMed 2602512 ↗
  • Byerly MJ, Nakonezny PA, Rush AJ. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res. 2008 Mar;100(1-3):60-9. doi: 10.1016/j.schres.2007.12.470. Epub 2008 Feb 5. PubMed 18255269 ↗
  • Draper ML, Stutes DS, Maples NJ, Velligan DI. Cognitive adaptation training for outpatients with schizophrenia. J Clin Psychol. 2009 Aug;65(8):842-53. doi: 10.1002/jclp.20612. PubMed 19521972 ↗
  • Fischer EP, McSweeney JC, Pyne JM, Williams DK, Naylor AJ, Blow FC, Owen RR. Influence of family involvement and substance use on sustained utilization of services for schizophrenia. Psychiatr Serv. 2008 Aug;59(8):902-8. doi: 10.1176/ps.2008.59.8.902. PubMed 18678688 ↗
  • Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005 Nov;15(9):1277-88. doi: 10.1177/1049732305276687. PubMed 16204405 ↗
  • McGurk SR, Mueser KT. Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr Res. 2004 Oct 1;70(2-3):147-73. doi: 10.1016/j.schres.2004.01.009. PubMed 15329293 ↗
  • McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007 Dec;164(12):1791-802. doi: 10.1176/appi.ajp.2007.07060906. PubMed 18056233 ↗
  • Reichenberg A, Harvey PD. Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull. 2007 Sep;133(5):833-58. doi: 10.1037/0033-2909.133.5.833. Erratum In: Psychol Bull. 2008 May;134(3):382. PubMed 17723032 ↗
  • Test MA, Greenberg JS, Long JD, Brekke JS, Burke SS. Construct validity of a measure of subjective satisfaction with life of adults with serious mental illness. Psychiatr Serv. 2005 Mar;56(3):292-300. doi: 10.1176/appi.ps.56.3.292. PubMed 15746503 ↗
  • van Wijngaarden B, Schene AH, Koeter M, Vazquez-Barquero JL, Knudsen HC, Lasalvia A, McCrone P. Caregiving in schizophrenia: development, internal consistency and reliability of the Involvement Evaluation Questionnaire--European Version. EPSILON Study 4. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Br J Psychiatry Suppl. 2000;(39):s21-7. doi: 10.1192/bjp.177.39.s21. PubMed 10945074 ↗
  • Velligan DI, Bow-Thomas CC, Huntzinger C, Ritch J, Ledbetter N, Prihoda TJ, Miller AL. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. Am J Psychiatry. 2000 Aug;157(8):1317-23. doi: 10.1176/appi.ajp.157.8.1317. PubMed 10910797 ↗
  • Velligan DI, Prihoda TJ, Ritch JL, Maples N, Bow-Thomas CC, Dassori A. A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophr Bull. 2002;28(2):283-92. doi: 10.1093/oxfordjournals.schbul.a006938. PubMed 12693434 ↗
  • Velligan DI, Lam F, Ereshefsky L, Miller AL. Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv. 2003 May;54(5):665-7. doi: 10.1176/appi.ps.54.5.665. No abstract available. PubMed 12719495 ↗
  • Velligan DI, Diamond PM, Mintz J, Maples N, Li X, Zeber J, Ereshefsky L, Lam YW, Castillo D, Miller AL. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull. 2008 May;34(3):483-93. doi: 10.1093/schbul/sbm111. Epub 2007 Oct 10. PubMed 17932089 ↗
  • Velligan DI, Diamond PM, Maples NJ, Mintz J, Li X, Glahn DC, Miller AL. Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia. Schizophr Res. 2008 Jul;102(1-3):312-9. doi: 10.1016/j.schres.2008.02.005. Epub 2008 Apr 18. PubMed 18374542 ↗
  • Kidd SA, Kerman N, Ernest D, Maples N, Arthur C, de Souza S, Kath J, Herman Y, Virdee G, Collins A, Velligan D. A pilot study of a family cognitive adaptation training guide for individuals with schizophrenia. Psychiatr Rehabil J. 2018 Jun;41(2):109-117. doi: 10.1037/prj0000204. Epub 2016 Aug 22. PubMed 27547853 ↗

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01768000
Lead sponsor
Centre for Addiction and Mental Health
Responsible party
Sean Kidd (Independent Clinician Scientist and Head Psychology Service, Centre for Addiction and Mental Health) — Principal investigator
First posted
Jan 15, 2013
Start date
Jan 2013
Primary completion
Oct 2014
Completion
Oct 2014
Results posted
Mar 1, 2016
Last update
Mar 1, 2016

Study contacts

Sean Kidd, Ph.D
principal investigator · Centre for Addiction and Mental Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion